Atlas FDA

COSMETIC TISSUE AUGMENTATION PRODUCT (CTA)

FDA premarket approval P050033/S003 · decided 2007-11-19

Approval details

PMA number
P050033
Supplement
S003
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
COSMETIC TISSUE AUGMENTATION PRODUCT (CTA)
Generic name
Implant, dermal, for aesthetic use
Applicant
Anika Therapeutics, Inc.
Date received
2007-09-06
Decision date
2007-11-19
Days to decision
74 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Beford, MA
Statement
APPROVAL FOR MODIFICATIONS TO MANUFACTURING EQUIPMENT AND PROCEDURES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Integrity™ Implant (K250997)Anika Therapeutics, Inc.2025-06-17
Tactoset® Injectable Bone Substitute (K231968)Anika Therapeutics, Inc.2023-12-20
Integrity Implant (K223538)Anika Therapeutics, Inc.2023-08-17
Integrity™ Bone Staple Fixation System (K223860)Anika Therapeutics, Inc.2023-05-22
Anika Tissue Tack Fixation System (K222487)Anika Therapeutics, Inc.2023-05-08
Tactoset (K223915)Anika Therapeutics, Inc.2023-03-29
Tactoset Injectable Bone Substitute (K212083)Anika Therapeutics, Inc.2021-08-31
SCS 17-01 (K190956)Anika Therapeutics, Inc.2020-01-30